These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21075060)

  • 21. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.
    Hurtado MO; Kohler I; de Lange EC
    Bioanalysis; 2018 Sep; 10(18):1525-1546. PubMed ID: 30198770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
    Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
    Yilmaz A; Geddes T; Han B; Bahado-Singh RO; Wilson GD; Imam K; Maddens M; Graham SF
    J Alzheimers Dis; 2017; 58(2):355-359. PubMed ID: 28453477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
    Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
    Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.
    Lleó A; Núñez-Llaves R; Alcolea D; Chiva C; Balateu-Paños D; Colom-Cadena M; Gomez-Giro G; Muñoz L; Querol-Vilaseca M; Pegueroles J; Rami L; Lladó A; Molinuevo JL; Tainta M; Clarimón J; Spires-Jones T; Blesa R; Fortea J; Martínez-Lage P; Sánchez-Valle R; Sabidó E; Bayés À; Belbin O
    Mol Cell Proteomics; 2019 Mar; 18(3):546-560. PubMed ID: 30606734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    J Pharm Biomed Anal; 2015 Mar; 107():75-81. PubMed ID: 25575172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
    PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.
    Xu XH; Huang Y; Wang G; Chen SD
    Neurosci Bull; 2012 Oct; 28(5):641-8. PubMed ID: 23054640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer's Disease.
    Hao L; Wang J; Page D; Asthana S; Zetterberg H; Carlsson C; Okonkwo OC; Li L
    Sci Rep; 2018 Jun; 8(1):9291. PubMed ID: 29915347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted metabolomics study of early pathological features in hippocampus of triple transgenic Alzheimer's disease male mice.
    Zhao Y; Chen H; Iqbal J; Liu X; Zhang H; Xiao S; Jin N; Yao F; Shen L
    J Neurosci Res; 2021 Mar; 99(3):927-946. PubMed ID: 33197957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Hair Metabolome in 5xFAD Mice and Patients with Alzheimer's Disease Using Mass Spectrometry-Based Metabolomics.
    Chang CW; Hsu JY; Lo YT; Liu YH; Mee-Inta O; Lee HT; Kuo YM; Liao PC
    ACS Chem Neurosci; 2024 Feb; 15(3):527-538. PubMed ID: 38269400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative Metabolomics in Alzheimer's Disease: Technical Considerations for Improved Reproducibility.
    Veiga S; Wahrheit J; Rodríguez-Martín A; Sonntag D
    Methods Mol Biol; 2018; 1779():463-470. PubMed ID: 29886550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating metabolic dysregulation in serum of triple transgenic Alzheimer's disease male mice: implications for pathogenesis and potential biomarkers.
    Zhuang H; Cao X; Tang X; Zou Y; Yang H; Liang Z; Yan X; Chen X; Feng X; Shen L
    Amino Acids; 2024 Feb; 56(1):10. PubMed ID: 38315232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study.
    Patkar AA; Rozen S; Mannelli P; Matson W; Pae CU; Krishnan KR; Kaddurah-Daouk R
    Psychopharmacology (Berl); 2009 Oct; 206(3):479-89. PubMed ID: 19649617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.
    Gevi F; Zolla L; Gabriele S; Persico AM
    Mol Autism; 2016; 7():47. PubMed ID: 27904735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease.
    Greenberg N; Grassano A; Thambisetty M; Lovestone S; Legido-Quigley C
    Electrophoresis; 2009 Apr; 30(7):1235-9. PubMed ID: 19288586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.